RadioBDC Logo
Baio | RadioBDC: Celebrity Series Takeover Listen Live

Test of antidepressant disappoints

Associated Press / November 9, 2011

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Drug maker AstraZeneca says a new antidepressant drug it hopes will be a big money-earner did not perform as well as expected in a test. AstraZeneca, which is developing the drug, known as TC-5214. in collaboration with U.S.-based Targacept, said Tuesday that the drug did not perform as well as hoped versus a placebo in the first of four tests in Phase III trials.

For more from, sign up or log in below

To continue, please sign up or log in to

Access the full articles and quality reporting of The Boston Globe at

Sign up

Unlimited Access to for 4 weeks for only 99¢.

Are you a Boston Globe home delivery subscriber?

Get FREE access as part of your print subscription. subscriber

Click to continue reading this article or to log in to